SS Innovations International Files 8-K
Ticker: SSII · Form: 8-K · Filed: Dec 16, 2025 · CIK: 1676163
Sentiment: neutral
Topics: 8-K, disclosure
TL;DR
SS Innovations (fka AVRA Medical Robotics) filed an 8-K on 12/16/25 for a Reg FD disclosure.
AI Summary
SS Innovations International, Inc. filed an 8-K on December 16, 2025, reporting a Regulation FD Disclosure. The company, formerly known as AVRA Medical Robotics, Inc. since June 1, 2016, is incorporated in Florida and has its principal executive offices in Gurugram, Haryana, India.
Why It Matters
This filing indicates a regulatory disclosure event for SS Innovations International, Inc., formerly AVRA Medical Robotics, Inc.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for a Regulation FD disclosure, which typically does not involve significant new financial or operational information.
Key Players & Entities
- SS Innovations International, Inc. (company) — Registrant
- AVRA Medical Robotics, Inc. (company) — Former company name
- December 16, 2025 (date) — Date of report
- Florida (location) — State of incorporation
- Gurugram, Haryana, India (location) — Principal executive office location
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on December 16, 2025.
What was SS Innovations International, Inc. formerly known as?
SS Innovations International, Inc. was formerly known as AVRA Medical Robotics, Inc.
On what date did the company change its name from AVRA Medical Robotics, Inc.?
The company changed its name from AVRA Medical Robotics, Inc. on June 1, 2016.
Where are the principal executive offices of SS Innovations International, Inc. located?
The principal executive offices of SS Innovations International, Inc. are located at 05, 3rd Floor, iLabs Info Technology Centre, Udyog Vihar, Phase III, Gurugram, Haryana, India.
Filing Stats: 841 words · 3 min read · ~3 pages · Grade level 13 · Accepted 2025-12-16 10:36:33
Filing Documents
- ea0269726-8k_ssinno.htm (8-K) — 27KB
- 0001213900-25-122031.txt ( ) — 191KB
- ssii-20251216.xsd (EX-101.SCH) — 3KB
- ssii-20251216_lab.xml (EX-101.LAB) — 33KB
- ssii-20251216_pre.xml (EX-101.PRE) — 22KB
- ea0269726-8k_ssinno_htm.xml (XML) — 4KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On November 13, 2025, Dr. Sudhir Srivastava our Chairman and Chief Executive Officer, gave an interview (the "Interview") with Nasdaq's Live From MarketSite. On December 16, 2025, the Interview was published and may be viewed at the Nasdaq Live From MarketSite website at https://www.nasdaq.com/solutions/listings/live-from-marketsite or on the Company's website at https://ssinnovations.com/investor-overview/. The information set forth in this Item 7.01 and in the Interview, are deemed to be "furnished" and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of that Section. The information set forth in this Item 7.01 and in the video interview, including without limitation, information accessed through the links set forth above, shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.
Forward-Looking Statements
Forward-Looking Statements This Report may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words "anticipate," "assume," "believe," "estimate," "expect," "will," "intend," "may," "plan," "project," "should," "could," "seek," "designed," "potential," "forecast," "target," "objective," "goal," or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SSi's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Some of the risks and uncertainties, although not all risks and uncertainties, that could cause the Company's actual results to differ materially from those presented in its forward-looking statements are set forth in the Company's Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q, and all of its other filings with the U.S. Securities and Exchange Commission, as such risks, uncertainties and other important factors may be updated from time to time in the Company's subsequent reports. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to SSi's operations, results of operations, growth strategy and liquidity. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 16, 2025 SS INNOVATIONS INTERNATIONAL, INC. By: /s/ Sudhir Srivastava Sudhir Srivastava, M.D. Chairman and Chief Executive Officer 2